Use of Rituximab in NHL Malt Type Pregnant in I° Trimester for Two Times

Administration of rituximab, one of the basic drugs for the therapy of B-cell lymphoproliferative diseases, during pregnancy has been suspected to cause developmental fetal events, particularly if given during the first trimester of pregnancy. Therefore, use in pregnancy is not permitted. Howe ver,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open Med (Wars)
Hauptverfasser: Sica, Antonello, Vitiello, Paola, Papa, Alfonso, Calogero, Armando, Sagnelli, Caterina, Casale, Danilo, Mottola, Maria, Svanera, Gino, Dodaro, Concetta Anna, Martinelli, Erika, Troiani, Teresa, Ciardiello, Fortunato, Casale, Beniamino
Format: Artigo
Sprache:Inglês
Veröffentlicht: De Gruyter 2019
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6884922/
https://ncbi.nlm.nih.gov/pubmed/31844674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/med-2019-0087
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge